6 results
8-K
ARAV
Aravive Inc
22 Mar 22
Aravive Appoints Scott Dove, Ph.D., as Chief Operating Officer
4:06pm
of its label expansion and lifecycle management clinical strategy. Dr. Dove previously oversaw the development of eluxadoline as program leader
8-K
EX-99.1
qwtpir3xlj4dqwukiyjy
22 Mar 22
Aravive Appoints Scott Dove, Ph.D., as Chief Operating Officer
4:06pm
- Prev
- 1
- Next